Teresa Cascella, MD
About Teresa Cascella, MD
Teresa Cascella, MD, is the Clinical Development Lead in Oncology at Bristol Myers Squibb, with extensive experience in clinical development and medical direction across various cancer types.
Current Role at Bristol Myers Squibb
Teresa Cascella, MD, is presently the Clinical Development Lead, Oncology at Bristol Myers Squibb. She is based in Boudry, Neuchatel, Switzerland. In this role, she oversees the clinical development of oncology projects, ensuring that clinical trials and research initiatives are conducted efficiently and effectively.
Previous Roles at Bristol Myers Squibb
Teresa Cascella previously served as the Senior Clinical Trial Physician, Oncology from 2021 to 2022 for six months in Basilea, Switzerland. During this time, she contributed to the planning and execution of clinical trials, enhancing the strategic development of oncology treatments.
Experience at Novartis Oncology
From 2013 to 2021, Teresa Cascella held several key roles at Novartis Oncology. These roles included Clinical Development Medical Director for GI Oncology, Lung Cancer, and Melanoma, as well as Global Brand Medical Director for Solid Tumors and Hematology. She was instrumental in clinical development and medical direction for multiple types of cancer, particularly gastrointestinal, lung cancer, melanoma, and hematological malignancies.
Research and Medical Advisory Positions
Teresa Cascella's extensive background in oncology research includes roles such as Research Associate at the University of North Carolina and Medical Advisor for endocrine-driven cancers at Ipsen. She has developed a robust foundation in research methodologies and medical advisory that has significantly contributed to her career in clinical development.
Education and Endocrinology Background
Teresa Cascella obtained her Doctor of Medicine (MD) and Doctor of Philosophy (PhD) in Endocrinology from the University of Naples Federico II between 1995 and 2006. She also gained extensive research and residency experience in endocrinology at the University of Catania and the European Institute of Oncology. Her strong foundation in endocrinology has been pivotal in her approach to clinical oncology.